The National Transport Authority are interested in hearing the views and concerns of people across Ireland in relation to accessibility of public transport in their area. They have created a survey which they have asked us to share with you.
Today, October 6th marks the first ever European Carers Day. Mary Devereux shares her thoughts on why carers need more care.
Ocrevus (ocrelizumab) is the first and only licensed treatment for people with early, inflammatory primary progressive multiple sclerosis in Ireland.
Dublin, 1st of October 2020 – Roche Products (Ireland) Ltd. (“Roche”), today, announced that OCREVUS® (ocrelizumab) is now publicly available in Ireland to treat people living with primary progressive multiple sclerosis (PPMS). More than 9,000 people in Ireland are living with MS(1) and it is estimated that PPMS, a highly disabling form of MS, and according to MS Ireland, affects approximately 15% of people diagnosed with MS(1).
Robert Joyce shares his opinion on what he would like to see the Government address in the upcoming budget.
Researchers at Trinity College Dublin and Beaumont Hospital are carrying out a study exploring cognitive changes (thinking and memory) in Multiple Sclerosis.
This week guest blogger Declan Groeger raises awareness of Make Way Day and accessibility.
Assistive Technology online workshops for people living with MS, their circle of support, family and friends.
'Among symptoms such as difficulties with cognition, decreasing mobility, fatigue, bowel and urinary issues- my symptoms are in all parts of my body- pain is always a major factor'
This week Mary Devereux shares with us her story of day to day living with MS and pain.
© 2010 - 2024 Multiple Sclerosis Society of Ireland